JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 1, 2009; DOI: 10.1124/jpet.109.150730


0022-3565/09/3301-162-168$20.00
JPET 330:162-168, 2009
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.109.150730v1
330/1/162    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Fricks, I. P.
Right arrow Articles by Harden, T. K.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fricks, I. P.
Right arrow Articles by Harden, T. K.

CELLULAR AND MOLECULAR

Gi-Dependent Cell Signaling Responses of the Human P2Y14 Receptor in Model Cell Systems

Ingrid P. Fricks, Rhonda L. Carter1, Eduardo R. Lazarowski, and T. Kendall Harden

Departments of Pharmacology (I.P.F., R.L.C., T.K.H.) and Medicine (E.R.L.) and the Cystic Fibrosis Center (E.R.L.), University of North Carolina School of Medicine, Chapel Hill, North Carolina

Eight G protein-coupled receptors comprise the P2Y receptor family of cell signaling proteins. The goal of the current study was to define native cell signaling pathways regulated by the uridine nucleotide sugar-activated P2Y14 receptor (P2Y14-R). The P2Y14-R was stably expressed in human embryonic kidney (HEK) 293 and C6 rat glioma cells by retroviral infection. Nucleotide sugar-dependent P2Y14-R activation was examined by measuring inhibition of forskolin-stimulated cAMP accumulation. The effect of P2Y14-R activation on mitogen-activated protein kinase signaling also was studied in P2Y14-HEK293 cells and in differentiated HL-60 human myeloid leukemia cells. UDP-Glc, UDP-galactose, UDP-glucuronic acid, and UDP-N-acetylglucosamine promoted inhibition of forskolin-stimulated cAMP accumulation in P2Y14-HEK293 and P2Y14-C6 cells, and this signaling effect was abolished by pretreatment of cells with pertussis toxin. Inhibition of cAMP formation by nucleotide sugars also was observed in direct assays of adenylyl cyclase activity in membranes prepared from P2Y14-C6 cells. UDP-Glc promoted concentration-dependent and pertussis toxin-sensitive extracellular signal-regulated kinase (ERK) 1/2 phosphorylation in P2Y14-HEK293 cells. P2Y14-R mRNA was not observed in wild-type HL-60 cells but was readily detected in dimethyl sulfoxide-differentiated cells. Consistent with this observation, no effect of UDP-Glc was observed in wild-type HL-60 cells, but UDP-Glc-promoted pertussis toxin-sensitive activation of ERK1/2 occurred after differentiation. These results illustrate that the human P2Y14-R signals through Gi to inhibit adenylyl cyclase, and P2Y14-R activation also leads to ERK1/2 activation. This work also identifies two stable P2Y14-R-expressing cell lines and differentiated HL-60 cells as model systems for the study of P2Y14-R-dependent signal transduction.


Received for publication January 11, 2009
Accepted March 31, 2009.

Address correspondence to: Dr. T. Kendall Harden, Department of Pharmacology, University of North Carolina, School of Medicine, Chapel Hill, NC 27599. E-mail: tkh{at}med.unc.edu







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2009 by the American Society for Pharmacology and Experimental Therapeutics.